ATE395600T1 - Verfahren zur diagnose von knochenmetastasen aus malignen tumoren - Google Patents

Verfahren zur diagnose von knochenmetastasen aus malignen tumoren

Info

Publication number
ATE395600T1
ATE395600T1 AT99938547T AT99938547T ATE395600T1 AT E395600 T1 ATE395600 T1 AT E395600T1 AT 99938547 T AT99938547 T AT 99938547T AT 99938547 T AT99938547 T AT 99938547T AT E395600 T1 ATE395600 T1 AT E395600T1
Authority
AT
Austria
Prior art keywords
bone metastasis
malignant tumors
diagnosing bone
marker
reflects
Prior art date
Application number
AT99938547T
Other languages
English (en)
Inventor
Etsuro Ogata
Mitsuru Koizumi
Shunji Takahashi
Original Assignee
Etsuro Ogata
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Etsuro Ogata filed Critical Etsuro Ogata
Application granted granted Critical
Publication of ATE395600T1 publication Critical patent/ATE395600T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AT99938547T 1998-08-21 1999-08-20 Verfahren zur diagnose von knochenmetastasen aus malignen tumoren ATE395600T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23614698 1998-08-21

Publications (1)

Publication Number Publication Date
ATE395600T1 true ATE395600T1 (de) 2008-05-15

Family

ID=16996446

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99938547T ATE395600T1 (de) 1998-08-21 1999-08-20 Verfahren zur diagnose von knochenmetastasen aus malignen tumoren

Country Status (7)

Country Link
US (1) US7632486B1 (de)
EP (1) EP1107006B1 (de)
JP (1) JP4420565B2 (de)
AT (1) ATE395600T1 (de)
AU (1) AU5302599A (de)
DE (1) DE69938729D1 (de)
WO (1) WO2000011480A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005064307A2 (en) 2003-12-23 2005-07-14 Roche Diagnostics Gmbh Method of assessing rheumatoid arthritis by measuring anti-ccp and interleukin 6
JP5010034B2 (ja) * 2007-12-28 2012-08-29 エフ．ホフマン−ラ ロシュ アーゲー 生理学的状態の評価
WO2012122334A2 (en) * 2011-03-08 2012-09-13 The Johns Hopkins University Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
EP2704717A1 (de) 2011-05-02 2014-03-12 Exelixis, Inc. Verfahren zur behandlung von krebs- und knochenkrebsschmerz
KR102599293B1 (ko) 2015-06-04 2023-11-07 니혼 메디피직스 가부시키가이샤 암의 조기 골 전이의 화상 진단제
US20210263038A1 (en) * 2018-08-03 2021-08-26 Cytogen, Inc. Composition for diagnosis of bone metastasis of cancer and kit comprising same
EP3832309B1 (de) * 2018-08-03 2023-11-01 Cytogen, Inc. Zusammensetzung zur diagnose von knochenmetastasen von krebs und kit mit dieser zusammensetzung
US20240125784A1 (en) * 2021-03-24 2024-04-18 Sekisui Medical Co., Ltd. Immunological analysis method for type-i collagen c-terminal telopeptide
CN117316426B (zh) * 2023-09-12 2026-01-20 上海市第六人民医院 基于骨转移特异性骨标志物的肿瘤骨转移预测系统及方法
CN121393909B (zh) * 2025-12-26 2026-03-24 海南省人民医院 基于骨转移特异性骨标志物的肿瘤骨转移预测系统及方法

Also Published As

Publication number Publication date
AU5302599A (en) 2000-03-14
EP1107006B1 (de) 2008-05-14
JP4420565B2 (ja) 2010-02-24
US7632486B1 (en) 2009-12-15
EP1107006A1 (de) 2001-06-13
DE69938729D1 (de) 2008-06-26
WO2000011480A1 (fr) 2000-03-02
EP1107006A4 (de) 2002-03-06

Similar Documents

Publication Publication Date Title
DE69738077D1 (de) Tiermodelle für die menschliche prostatakrebsfortschreitung
ATE294595T1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
DE69839682D1 (de) Pharmazeutische Zusammensetzungen enthaltend Arsentrioxid zur Behandlung von nicht-Hodgkihn-Lymphome
DE69730820D1 (de) Polyazomacrocyclofluoromonoalkylphosphensäure, ihre komplexe zur verwendung als kontrastmittel
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
ATE345387T1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
ATE469242T1 (de) Zusammensetzungen und methoden zur identifizierung und zum targeting von krebszellen aus dem verdauungskanal
EP1257287A4 (de) Verbindungen und methoden zur frühdiagnose von eierstockkrebs
ATE522623T1 (de) Zusammensetzungen und verfahren zur behandlung und diagnose von lungentumoren
EP0967015A3 (de) Verwendung von Ferrocenylliganden zur katalytischen enantioselektiven Hydrierung
DE69938729D1 (de) Verfahren zur diagnose von knochenmetastasen aus malignen tumoren
JP2002513368A5 (de)
DE60016548D1 (de) Snail, neuer marker für die entwicklung von tumoren und zielprotein neuer antitumoraler verbindungen
IL151448A0 (en) Proteins
DE69927688D1 (de) Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs
EP1446013A4 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
ATE306668T1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
WO2003037257A3 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
DE60030270D1 (de) Fettsaure analoge zur diagnose von kranzarterie erkrankungen
ATE435284T1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
ATE329597T1 (de) Die verwendung von einer 4- pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren
DE10296200D2 (de) Verfahren zur Diagnose von Brustkrebserkrankungen, zugehörige Peptide und deren Verwendungen
DE69931644D1 (de) Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen
ATE240352T1 (de) Komplexverbindungen zur diagnose von gefässerkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties